Gene · 10220
Papers1,347
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,347
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Follistatin drives AR-independent prostate cancer through BMP signaling inactivation and microenvironmental remodeling. | Proc Natl Acad Sci U S A | 2026 | 42784510 | PubTator, text mining | PubMed |
| PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines. | Mol Ther Nucleic Acids | 2026 | 42732236 | PubTator, text mining | PubMed |
| Serum BAFF and GDF11: cross-sectional associations with glycolipid metabolism and subclinical carotid artery wall thickening in elderly type 2 diabetes patients. | Front Cardiovasc Med | 2026 | 42682957 | PubTator, text mining | PubMed |
| The crystal structure of the activin B:Fst288 complex and computational insights into the broad antagonistic activity and specificity of follistatin. | J Biol Chem | 2026 | 42607890 | PubTator, text mining | PubMed |
| Association of serum growth differentiation factor 11 with asthma severity, inflammation, and airway remodeling in pediatric patients. | Front Med (Lausanne) | 2026 | 42548683 | PubTator, text mining | PubMed |
| Preclinical development of an extended half-life anti-myostatin monoclonal antibody. | Sci Rep | 2026 | 42380199 | PubTator, text mining | PubMed |
| Exercise-induced myokines in metabolic regulation: mechanisms, mimetics, and translational potential. | Arch Pharm Res | 2026 | 42315824 | PubTator, text mining | PubMed |
| Growth differentiation factor-11 inhibits the progression of acute myeloid leukemia and increases chemosensitivity by inhibiting cathepsin S. | Anticancer Drugs | 2026 | 42307925 | PubTator, text mining | PubMed |
| Growth differentiation factor 11 (GDF11) signaling in neural stem cell regulation: molecular and cellular insights. | Rev Neurosci | 2026 | 42299745 | PubTator, text mining | PubMed |
| A Multimodal Framework for Alzheimer's Prevention: Diet, Exercise, Fasting, Sleep, and Gut Microbiota. | Curr Alzheimer Res | 2026 | 42099162 | PubTator, text mining | PubMed |
| Growth differentiation factor-11 stimulates human extravillous trophoblast cell invasion by upregulating Slug-mediated N-cadherin expression. | Placenta | 2026 | 42097099 | PubTator, text mining | PubMed |
| Evaluation of correlation of GDF11 and atherogenic factors in patients with diabetic dyslipidemia. | Pol Merkur Lekarski | 2026 | 42048502 | PubTator, text mining | PubMed |
| The long non-coding RNA KDM4A-AS1 protects β-cell function via the miR-423-5p/growth differentiation factor 11 axis. | Diabet Med | 2026 | 41931382 | PubTator, text mining | PubMed |
| Growth Differentiation Factor 11 Promotes Corneal Endothelial Injury Repair by Activating the SRY-Box Transcription Factor 9-β-Catenin Signaling Pathway. | Am J Pathol | 2026 | 41903789 | PubTator, text mining | PubMed |
| BMPR2 Dosage Gates BMP9/10 Signaling Output in Pulmonary Artery Endothelium. | Cells | 2026 | 41892283 | PubTator, text mining | PubMed |
| Advancements and Challenges in Tissue-Engineered Heart Valves: Integrating Biomechanics, Biomaterials, and Biomimetic Design for Functional Maturity. | Biomimetics (Basel) | 2026 | 41892108 | PubTator, text mining | PubMed |
| Growth factor applications and clinical translation: advances and challenges. | Ann Med | 2026 | 41837883 | PubTator, text mining | PubMed |
| Elevated circulating GDF11 and its role in age-related sarcopenia: insights from clinical, transcriptomic, and in vitro analyses. | Front Aging | 2026 | 41822302 | PubTator, text mining | PubMed |
| Enablers of community-led action in Australian climate disasters: recognising the role of pre-existing social foundations and local knowledges. | Disasters | 2026 | 41814583 | PubTator, text mining | PubMed |
| Kill two birds with one stone: Reprogramming tumor microenvironment with growth differentiation factor 11. | World J Gastroenterol | 2026 | 41810435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10220/papers